These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11267048)

  • 1. Transgenic pigs with human N-acetylglucosaminyltransferase III.
    Miyagawa S; Murakami H; Murase A; Nakai R; Koma M; Koyota S; Matsunami K; Takahagi Y; Fujimura T; Shigehisa T; Nagashima H; Shirakura R; Taniguchi N
    Transplant Proc; 2001; 33(1-2):742-3. PubMed ID: 11267048
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys.
    Komoda H; Miyagawa S; Omori T; Takahagi Y; Murakami H; Shigehisa T; Ito T; Matsuda H; Shirakura R
    Xenotransplantation; 2005 May; 12(3):209-16. PubMed ID: 15807771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III.
    Takahagi Y; Miyagawa S; Murakami H; Matsunami K; Fujimura T; Shigehisa T; Shirakura R
    Transplant Proc; 2003 Feb; 35(1):516-7. PubMed ID: 12591510
    [No Abstract]   [Full Text] [Related]  

  • 4. Significant downregulation of the major swine xenoantigen by N-acetylglucosaminyltransferase III gene transfection.
    Tanemura M; Miyagawa S; Ihara Y; Matsuda H; Shirakura R; Taniguchi N
    Biochem Biophys Res Commun; 1997 Jun; 235(2):359-64. PubMed ID: 9199197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig.
    Miyagawa S; Murakami H; Takahagi Y; Nakai R; Yamada M; Murase A; Koyota S; Koma M; Matsunami K; Fukuta D; Fujimura T; Shigehisa T; Okabe M; Nagashima H; Shirakura R; Taniguchi N
    J Biol Chem; 2001 Oct; 276(42):39310-9. PubMed ID: 11486004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling of the major mouse xenoantigen, Galalpha1-3Galbeta1-4GlcNAc-R, by N-acetylglucosaminyltransferase-III.
    Chung TW; Kim KS; Kang SK; Lee JW; Song EY; Chung TH; Yeom YI; Kim CH
    Mol Cells; 2003 Dec; 16(3):343-53. PubMed ID: 14744025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the xenoantigen Gal alpha(1,3)Gal by N-acetylglucosaminyltransferase III (GnT-III) in transgenic mice.
    Tanemura M; Miyagawa S; Ihara Y; Nishikawa A; Suzuki M; Yamamura K; Matsuda H; Shirakura R; Taniguchi N
    Transplant Proc; 1997; 29(1-2):895-6. PubMed ID: 9123576
    [No Abstract]   [Full Text] [Related]  

  • 8. Cynomolgus monkey did not hyperacutely reject skin xenograft of N-acetylglucosaminyltransferase III gene transgenic pig.
    Fujita T; Machida K; Matsumoto Y; Saito T; Sato N; Takahagi Y; Murakami H; Miyagawa S; Shirakura R; Taniguchi N
    Transplant Proc; 2003 Feb; 35(1):518. PubMed ID: 12591511
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin graft of double transgenic pigs of N-acetylglucosaminyltransferase III (GnT-III) and DAF (CD55) genes survived in cynomolgus monkey for 31 days.
    Fujita T; Miyagawa S; Ezoe K; Saito T; Sato N; Takahagi Y; Murakami H; Matsunami K; Shirakura R; Taniguchi N
    Transpl Immunol; 2004 Dec; 13(4):259-64. PubMed ID: 15589738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of the major swine xenoantigen Gal alpha (1,3)Gal by transfection of N-acetylglucosaminyl transferase III (GnT-III) gene.
    Tanemura M; Miyagawa S; Ihara Y; Mikata S; Matsuda H; Shirakura R; Taniguchi N
    Transplant Proc; 1997; 29(1-2):891-2. PubMed ID: 9123573
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of alpha 1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III.
    Takahagi Y; Fujimura T; Miyagawa S; Nagashima H; Shigehisa T; Shirakura R; Murakami H
    Mol Reprod Dev; 2005 Jul; 71(3):331-8. PubMed ID: 15806557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning of pigGnT-I and I.2: an application to xenotransplantation.
    Matsunami K; Miyagawa S; Nakagawa K; Otsuka H; Shirakura R
    Biochem Biophys Res Commun; 2006 May; 343(3):677-83. PubMed ID: 16563346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on carbohydrate xenoantigens.
    Christiansen D; Mouhtouris E; Ramsland PA; Sandrin MS
    Methods Mol Biol; 2012; 885():47-56. PubMed ID: 22565989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylglucosaminyltransferase (GnT) assays using fluorescent oligosaccharide acceptor substrates: GnT-III, IV, V, and IX (GnT-Vb).
    Takamatsu S; Korekane H; Ohtsubo K; Oguri S; Park JY; Matsumoto A; Taniguchi N
    Methods Mol Biol; 2013; 1022():283-98. PubMed ID: 23765669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating Xenoantigen Expression on Swine RBC.
    Wang ZY; Martens GR; Blankenship RL; Sidner RA; Li P; Estrada JL; Tector M; Tector AJ
    Transplantation; 2017 Mar; 101(3):517-523. PubMed ID: 27379553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the Gal-alpha1,3-Gal epitope of mouse endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene.
    Chung TW; Kim KS; Kim CH
    Mol Cells; 2003 Dec; 16(3):368-76. PubMed ID: 14744028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to overcome hyperacute rejection of pig-to-human xenografts.
    McKenzie IF; Osman N; Cohney S; Sandrin MS
    Transplant Proc; 1997; 29(1-2):973-4. PubMed ID: 9123613
    [No Abstract]   [Full Text] [Related]  

  • 18. Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I.
    Zhang W; Betel D; Schachter H
    Biochem J; 2002 Jan; 361(Pt 1):153-62. PubMed ID: 11742540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha1,3GalT knockout/alpha1,2FucT transgenic pig does not appear to have an advantage over the alpha1,3GalT knockout pig with respect to glycolipid reactivity with human serum antibodies.
    Diswall M; Benktander J; Ångström J; Teneberg S; Breimer ME
    Xenotransplantation; 2014; 21(1):57-71. PubMed ID: 24219248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration?
    Lee W; Long C; Ramsoondar J; Ayares D; Cooper DK; Manji RA; Hara H
    Xenotransplantation; 2016 Sep; 23(5):370-80. PubMed ID: 27511593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.